Krechler T - Search Results

1

Antioxidant status and oxidative stress markers in pancreatic cancer and chronic pancreatitis.

Kodydkova J, Vavrova L, Stankova B, Macasek J, Krechler T, Zak A. Kodydkova J, et al. Among authors: krechler t. Pancreas. 2013 May;42(4):614-21. doi: 10.1097/MPA.0b013e318288360a. Pancreas. 2013. PMID: 23558240

2

Chronic pancreatitis and the composition of plasma phosphatidylcholine fatty acids.

Zeman M, Macášek J, Burda M, Tvrzická E, Vecka M, Krechler T, Staňková B, Hrabák P Jr, Žák A. Zeman M, et al. Among authors: krechler t. Prostaglandins Leukot Essent Fatty Acids. 2016 May;108:38-44. doi: 10.1016/j.plefa.2016.03.012. Epub 2016 Mar 24. Prostaglandins Leukot Essent Fatty Acids. 2016. PMID: 27154363

3

Osteopontin as a discriminating marker for pancreatic cancer and chronic pancreatitis.

Rychlíková J, Vecka M, Jáchymová M, Macášek J, Hrabák P, Zeman M, Vávrová L, Řoupal J, Krechler T, Ák A. Rychlíková J, et al. Among authors: krechler t. Cancer Biomark. 2016 Jun 7;17(1):55-65. doi: 10.3233/CBM-160617. Cancer Biomark. 2016. PMID: 27314293

4

Paraoxonase-1 (PON1) status in pancreatic cancer: relation to clinical parameters.

Vecka M, Jáchymová M, Vávrová L, Kodydková J, Macášek J, Urbánek M, Krechler T, Slabý A, Dušková J, Muravská A, Zák A. Vecka M, et al. Among authors: krechler t. Folia Biol (Praha). 2012;58(6):231-7. Folia Biol (Praha). 2012. PMID: 23438848 Free article.

5

[Current status of pancreatic cancer diagnosis].

Krechler T, Horejs J, Ulrych J, Zeman M, Macásek J, Dusková J, Zák A. Krechler T, et al. Cas Lek Cesk. 2011;150(11):587-93. Cas Lek Cesk. 2011. PMID: 22292339 Review. Czech.

6

Plasma fatty acid composition in patients with pancreatic cancer: correlations to clinical parameters.

Macášek J, Vecka M, Žák A, Urbánek M, Krechler T, Petruželka L, Staňková B, Zeman M. Macášek J, et al. Among authors: krechler t. Nutr Cancer. 2012;64(7):946-55. doi: 10.1080/01635581.2012.716138. Nutr Cancer. 2012. PMID: 23061902

7

Novel biochemical markers for non-invasive detection of pancreatic cancer.

Hrabák P, Šoupal J, Kalousová M, Krechler T, Vočka M, Hanuš T, Petruželka L, Svačina Š, Žák A, Zima T. Hrabák P, et al. Among authors: krechler t. Neoplasma. 2022 Mar;69(2):474-483. doi: 10.4149/neo_2022_210730N1075. Epub 2022 Feb 10. Neoplasma. 2022. PMID: 35144477

8

Ferritin as an independent mortality predictor in patients with pancreas cancer. Results of a pilot study.

Kalousová M, Krechler T, Jáchymová M, Kuběna AA, Zák A, Zima T. Kalousová M, et al. Among authors: krechler t. Tumour Biol. 2012 Oct;33(5):1695-700. doi: 10.1007/s13277-012-0426-z. Epub 2012 Aug 10. Tumour Biol. 2012. PMID: 22875781

9

Soluble receptor for advanced glycation end-products (sRAGE) and polymorphisms of RAGE and glyoxalase I genes in patients with pancreas cancer.

Krechler T, Jáchymová M, Mestek O, Zák A, Zima T, Kalousová M. Krechler T, et al. Clin Biochem. 2010 Jul;43(10-11):882-6. doi: 10.1016/j.clinbiochem.2010.04.004. Epub 2010 Apr 14. Clin Biochem. 2010. PMID: 20398646

10

[Our experience with pancreatic cancer and its relation to diabetes mellitus].

Krechler T, Zeman M, Vecka M, Jáchymová M, Horejs J, Krska Z, Ulrych J, Dusková J, Zák A. Krechler T, et al. Cas Lek Cesk. 2010;149(6):291-6. Cas Lek Cesk. 2010. PMID: 20662478 Czech.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

38 results

Search Page

Filters